News

Does the 23andMe Acquisition Make Regeneron a Buy Now?
Regeneron (NASDAQ: REGN) entered an agreement to acquire 23andMe for $256 million, which is a tiny fraction of its previous ...
23andMe bankruptcy prompts Cornyn-Grassley-Klobuchar bipartisan bill to protect sensitive genetic data
Republican Sen. John Cornyn and Democratic Sen. Amy Klobuchar are rolling out a measure to protect sensitive genetic data ...
23andMe to Be Bought by Biotech Company for $256 Million
Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...
Regeneron to buy 23andMe out of bankruptcy for $256 million
Regeneron, a biotech company, will acquire 23andMe for $256 million and vowed to comply with the genetic testing company's ...
23andMe was once worth $6 billion. What's left of the DNA testing startup is being bought for $256 million.
Regeneron is buying the assets of 23andMe, which filed for Chapter 11 bankruptcy in March after facing a series of hurdles ...
Genetic data will be safeguarded with 23andMe sale, drugmaker vows
The pharmaceutical giant plans to continue offering 23andMe’s DNA testing service and pledged to adopt its privacy practices ...
Bailey issues consumer alert to 23andMe customers following bankruptcy filing
Missouri Attorney General Andrew Bailey is alerting residents after biotechnology company 23andMe filed for bankruptcy in ...
23andMe Holding Co. (OTC:MEHCQ) Was Worth A Lot More Than People Thought, Says Jim Cramer
We recently published a list of Jim Cramer Reveals “Quiet” Stock That Goes Up In This List Of 12 Stocks. In this article, we ...